This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Genentech, Inc.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2025
Title: The Innovative Contributions of Susan C. Fisher
Introduction: Susan C. Fisher, an accomplished inventor based in San Carlos, CA, has made significant strides in the field of biotechnology. With a remarkable portfolio of six patents, she has contributed to the understanding and development of therapeutic antibodies and recombinant polypeptides. Her work exemplifies the intersection of scientific innovation and practical application.
Latest Patents: Among her latest contributions are patents focused on methods and compositions comprising purified recombinant polypeptides. These polypeptides are isolated from Chinese hamster ovary host cells, and include various antibodies, notably therapeutic antibodies. The patents detail the methods of making and utilizing these polypeptides, which are pivotal in advancing medical treatments and therapies.
Career Highlights: Susan C. Fisher is affiliated with Genentech, Inc., a leading biotechnology company known for its cutting-edge research and development. Her position at Genentech underscores her role in an innovative environment where she can channel her expertise into impactful projects. Over the years, Fisher has developed a robust body of work that highlights her dedication to enhancing therapeutic methodologies.
Collaborations: Working alongside distinguished colleagues such as X Christopher Yu and Ailen M. Sanchez, Fisher has fostered an environment of collaboration. Their collective efforts have pushed the boundaries of current biotechnological applications, exemplifying the power of teamwork in scientific discovery.
Conclusion: Susan C. Fisher stands out as a notable inventor whose work in purifying recombinant polypeptides and therapeutic antibodies is reshaping the landscape of biotechnology. With her extensive patent portfolio and collaborations at Genentech, Inc., she is a striking example of how innovative thinking can lead to significant advancements in medicine and healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
